Status:
RECRUITING
Longitudinal Registry Including Patients Treated With Heavy Particles
Lead Sponsor:
CNAO National Center of Oncological Hadrontherapy
Conditions:
Cancer
Oncology
Eligibility:
All Genders
Brief Summary
The purpose of this registry is to collect retrospective and prospective standardized data of patients treated with particle therapy, either with protons or carbon ions, at the National Center for Onc...
Detailed Description
Hadrontherapy is a unique radiotherapy (RT) that uses positively charged particles, namely protons and carbons, rather than photons used in conventional RT, to treat cancer. Particle therapy represen...
Eligibility Criteria
Inclusion
- Patients treated with heavy particles at Fondazione CNAO, Pavia
- Patients who have the ability to understand and be willing to sign a written informed consent document
Exclusion
- Patients or legal guardians who are unable to understand informed consent document
Key Trial Info
Start Date :
June 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 4 2071
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT05203250
Start Date
June 4 2021
End Date
June 4 2071
Last Update
August 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Center for Oncological Hadrontherapy (CNAO)
Pavia, Italy, 27100